Carcinoid Syndrome Efficacy Study Featuring an Oral Daily Paltusotine Regimen

Clinical trial NCT07087054 · RECRUITING

Trial details

NCT number: NCT07087054
Sponsor: Crinetics Pharmaceuticals Inc.
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Carcinoid Syndrome Carcinoid Carcinoid Tumor Carcinoid Tumor of Ileum Carcinoid Tumor of Cecum Carcinoid Tumor of Liver Carcinoid Tumor of Pancreas Carcinoid Syndrome Diarrhea Carcinoid Intestine Tumor

Start date: 2025-11-19
Primary completion: 2027-08-01
Enrollment: 141

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.